Navigation Links
Drugstore of the future -- new drugs from an old source
Date:11/10/2010

Toronto, ON (Nov. 10 2010) Supported by thousands of years of use, a new wave of polymolecular botanical drugs (PBDs), backed by strong biomedical research and clinical trials, are growing in acceptance as a viable new drug category for the treatment and prevention of a wide spectrum of diseases from cancer to obesity.

Leading researchers in drug development from the National Cancer Institute, Wake Forest University, the University of California, the Scripps Centre for Integrative Medicine, King's College in London UK, and many Canadian Universities will be among the twenty panellists at a Toronto forum on November 15th. Speakers will highlight recent discoveries, discuss current and future research, and chart regulatory landscapes for the promising field of polymolecular drug development. Treatment areas include diabetes, cholesterol management, and cancer.

Research findings will be presented illustrating the advances in the development of polymolecular drugs and their growing recognition as potential mainstream therapies to not only treat illness, but to prevent it. Since polymolecular drugs are composed of multiple components, they often produce biological and/or clinical efficacy through multiple mechanisms of action rather than through a single pathway, as conventional drugs do. An added advantage of this new class of drugs is the synergy between their components, which allows for lower concentrations of each individual ingredient with no reduction in efficacy. As a result they are, as a category, safer and more tolerable than conventional drugs.

Discussion will also focus on recent successes in standardization, which overcome the greatest challenge of botanical medicine and allow for assurances of consistency, safety, and efficacy.

The list of speakers at the forum will include:

  • Dr. Erminia Guarneri, founder and medical director of the Scripps Center for Integrative Medicine, who will deliver the keynote address, titled Personalized, Predictive, Pro-Active Health: Treating the Whole Person, Body, Mind & Spirit
  • Dr. Pierre Haddad, Professor at the University of Montreal presenting on novel anti-obesity and anti-diabetic properties of plants originating from the Boreal forest of Canada.
  • Dr. Peter Hyland: Professor, King's College, UK, presenting on novel standardization methods for polymolecular drugs.
  • Dr. Auro del Giallo, ABC Foundation School of Medicine, San Paulo Brazil presenting on polymolecular drugs and their role in treating cancer related fatigue
  • Dr. Jeffrey White, MD, Director, Office of Cancer Complementary and Alternative Medicine, National Cancer Institute, NIH, DHHS presenting on the US National Cancer Institute and its botanical research

Academic and clinical researchers, business development professionals and government agencies involved in the drug development field have been invited to attend and learn about this emerging field of health and therapeutics, and to network with other professionals in the field.


'/>"/>

Contact: Dr. Bhagirath Singh
bhagi.singh@schulich.uwo.ca
416-644-2287
CV Technologies Inc.
Source:Eurekalert

Related biology news :

1. An underwater drugstore?
2. Putting a bulls-eye on the flu: Paper details influenzas structure for future drug targeting
3. Shaping the future of the High Plains water supply
4. For future chips, smaller must also be better
5. ‘Scientific leaders of the future’ gear up for important talks on Capitol Hill
6. Lead-free piezoelectric materials of the future
7. Louisiana Tech forestry professor helps to shape future of global industry research
8. Glorious gadolinium gives flash memory a future
9. A future with or without trees
10. Unaccounted feedbacks from climate-induced ecosystem changes may increase future climate warming
11. Food for our future -- its more than whats for dinner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... , ... March 21, 2017 , ... ... , more than tripling its goal and raising over $30,000 in the first ... that grows nutritious veggies & herbs fast, easy, and affordably, anywhere. , “Simply ...
(Date:3/22/2017)... Washington, USA, and CARDIFF, UK (PRWEB) , ... March 21, 2017 ... ... regional blood flow and tissue oxygenation, is being explored as a way to track ... near-infrared spectroscopy study on tonic pain activation by cold pressor test ,” published today ...
(Date:3/22/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... Chaim Lebovits , Chief Executive Officer, will provide ... at Sachs Associates 2 nd Annual Neuroscience Biopartnering ... at the New York Academy of Sciences. ...
(Date:3/22/2017)... SAN FRANCISCO , March 22, 2017 /PRNewswire/ ... the fastest growing genetic information companies, today announced ... the diagnosis of Spinal Muscular Atrophy (SMA) ... the leading lethal genetic disorders among infants as ... disease in childhood. The new test, announced during ...
Breaking Biology Technology: